Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison

被引：0
|
作者：
M. Gorschlüter
C. Hahn
A. Fixson
U. Mey
C. Ziske
E. Molitor
R. Horré
T. Sauerbruch
G. Marklein
I. G. H. Schmidt-Wolf
A. Glasmacher
机构：
[1] University of Bonn,Department of Internal Medicine I
[2] University of Bonn,Department of Medical Microbiology and Immunology
来源：
Supportive Care in Cancer | 2003年 / 11卷
关键词：
Neutropenia; Acute leukemia; Febrile infections; Empiric antibiotic therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：362 / 370
页数：8
相关论文
共 16 条
  • [1] Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies:: a randomized comparison
    Gorschlüter, M
    Hahn, C
    Fixson, A
    Mey, U
    Ziske, C
    Molitor, E
    Horré, R
    Sauerbruch, T
    Marklein, G
    Schmidt-Wolf, IGH
    Glasmacher, A
    SUPPORTIVE CARE IN CANCER, 2003, 11 (06) : 362 - 370
  • [2] PIPERACILLIN TAZOBACTAM PLUS GENTAMICIN AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCY
    KELSEY, SM
    WEINHARDT, B
    POCOCK, CE
    SHAW, E
    NEWLAND, AC
    JOURNAL OF CHEMOTHERAPY, 1992, 4 (05) : 281 - 285
  • [3] Piperacillin-tazobactam as empiric monotherapy in febrile neutropenic patients with haematological malignancies
    Hazel, DL
    Graham, J
    Dickinson, JP
    Newland, AC
    Kelsey, SM
    JOURNAL OF CHEMOTHERAPY, 1997, 9 (04) : 267 - 272
  • [4] Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients
    Viscoli, C
    Cometta, A
    Kern, WV
    De Bock, R
    Paesmans, M
    Crokaert, F
    Glauser, MP
    Calandra, T
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (03) : 212 - 216
  • [5] A randomized monocentric trial in febrile neutropenic patients:: ceftriaxone and gentamicin vs cefepime and gentamicin
    Cornely, OA
    Bethe, U
    Seifert, H
    Breuer, K
    Schütt-Gerowitt, H
    Salzberger, B
    Schrappe, M
    Fätkenheuer, G
    ANNALS OF HEMATOLOGY, 2002, 81 (01) : 37 - 43
  • [6] Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
    José C Álvarez
    Sonia I Cuervo
    Javier R Garzón
    Julio C Gómez
    Jorge Augusto Díaz
    Edelberto Silva
    Ricardo Sánchez
    Jorge A Cortés
    BMC Pharmacology and Toxicology, 14
  • [7] Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
    Alvarez, Jose C.
    Cuervo, Sonia I.
    Garzon, Javier R.
    Gomez, Julio C.
    Diaz, Jorge Augusto
    Silva, Edelberto
    Sanchez, Ricardo
    Cortes, Jorge A.
    BMC PHARMACOLOGY & TOXICOLOGY, 2013, 14 : 59
  • [8] Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies
    Yasuda, Takahiko
    Suzuki, Ritsuro
    Ishikawa, Yuichi
    Terakura, Seitaro
    Inamoto, Yoshihiro
    Yanada, Masamitsu
    Nagai, Hirokazu
    Ozawa, Yukiyasu
    Ozeki, Kazutaka
    Atsuta, Yoshiko
    Emi, Nobuhiko
    Naoe, Tomoki
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (06) : E385 - E390
  • [9] Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia
    Weber, Nicholas
    Jackson, Kathryn
    McWhinney, Brett
    Ungerer, Jacobus
    Kennedy, Glen
    Lipman, Jeffrey
    Roberts, Jason A.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (07) : 503 - 508
  • [10] Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy
    Griggs, JJ
    Blair, EA
    Norton, JR
    Rowe, JM
    Flesher, WR
    Betts, RF
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 58 (04) : 293 - 297
12